{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:23:42Z","timestamp":1772720622731,"version":"3.50.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p>We aimed to evaluate the expression levels and the prognostic value of growth arrest specific 5 (GAS5) and runt-related transcription factor 1 (RUNX1) genes in children with ITP. This prospective cohort study included 100 patients with newly diagnosed ITP (patient group) and 100 healthy children of matched age and sex (control group). We evaluated the expression levels of both GAS5 and RUNX1 genes at the time of diagnosis before the introduction of treatment. GAS5 was under-expressed, while RUNX1 was over-expressed among the newly diagnosed ITP children compared with the control group. Patients with GAS5 levels &gt;0.50 had a significantly faster recovery compared with patients with levels\u22640.50 while patients with levels of RUNX1\u22642.6 had a significantly faster recovery compared with patients with levels &gt;2.6. The best cut-off values of GAS5 and RUNX1 to predict complete recovery of ITP were \u02c30.40 and \u02c23.18, respectively, yielding a sensitivity of 76.47% and 79.41%, respectively. The best cut-off values of GAS5 and RUNX1 expression that predict chronic ITP were \u02c20.17 and \u02c34.1, respectively, yielding sensitivity of 88.89% and 77.78%, respectively. GAS5 and RUNX1 could be useful markers in children with primary ITP to predict disease course.<\/jats:p>","DOI":"10.1097\/mph.0000000000002580","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T17:16:17Z","timestamp":1675358177000},"page":"e395-e400","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["lncRNA GAS5 and RUNX1 Genes in Children With Primary Immune Thrombocytopenia"],"prefix":"10.1097","volume":"45","author":[{"given":"Hossam","family":"Hodeib","sequence":"first","affiliation":[{"name":"Clinical Pathology Department, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7836-1170","authenticated-orcid":false,"given":"Doaa","family":"El Amrousy","sequence":"additional","affiliation":[{"name":"Pediatric Department, Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Elaskary","sequence":"additional","affiliation":[{"name":"Pediatric Department, Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahed","family":"Hablas","sequence":"additional","affiliation":[{"name":"Pediatric Department, Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira","family":"Youssef","sequence":"additional","affiliation":[{"name":"Clinical Pathology Department, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Abdelhai","sequence":"additional","affiliation":[{"name":"Clinical Pathology Department, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/jcm6020016","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey","year":"2017","journal-title":"J Clin Med"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ajh.21616","article-title":"The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports","volume":"85","author":"Terrell","year":"2010","journal-title":"Am J Hematol"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/bjh.16327","article-title":"Safety and efficacy of eltrombopag plus pulsed dexamethasone as first-line therapy for immune thrombocytopenia","volume":"189","author":"Zhang","year":"2020","journal-title":"Br J Haematol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1067\/S0022-3476(03)00245-2","article-title":"Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort","volume":"143","author":"Rosth\u00f8j","year":"2003","journal-title":"J Pediatr"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1182\/blood-2018-02-830844","article-title":"Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial","volume":"132","author":"Heitink-Poll\u00e9","year":"2018","journal-title":"Blood"},{"issue":"4 Pt 2","key":"R6-20250804","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.lpm.2014.01.010","article-title":"Pathogenesis of immune thrombocytopenia","volume":"43","author":"Cines","year":"2014","journal-title":"Presse Med"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0609.2006.00780.x","article-title":"Abnormality of CD4 (+) CD25 (+) regulatory T cells in idiopathic thrombocytopenic purpura","volume":"78","author":"Liu","year":"2007","journal-title":"Eur J Haematol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V98.4.952","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura","volume":"98","author":"Stasi","year":"2001","journal-title":"Blood"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/bjh.12480","article-title":"Cellular immune dysfunction in immune thrombocytopenia (ITP)","volume":"163","author":"McKenzie","year":"2013","journal-title":"Br J Haematol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"11005","DOI":"10.2147\/CMAR.S270464","article-title":"Long-chain non-coding SOX21-AS1 promotes proliferation and migration of breast cancer cells through the PI3K\/AKT signaling pathway","volume":"12","author":"Sheng","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canlet.2020.10.047","article-title":"lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-KB signaling in glioblastoma","volume":"498","author":"Tang","year":"2021","journal-title":"Cancer Lett"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1139\/bcb-2017-0188","article-title":"LncRNA SNHG1 enhances cell proliferation, migration, and invasion in cervical cancer","volume":"96","author":"Liu","year":"2018","journal-title":"Biochem Cell Biol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"494","DOI":"10.21037\/atm.2019.08.37","article-title":"Long non-coding RNAs in diseases related to inflammation and immunity","volume":"7","author":"Chen","year":"2019","journal-title":"Ann Transl Med"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"23650","DOI":"10.18632\/oncotarget.15569","article-title":"Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"BSR20180626","DOI":"10.1042\/BSR20180626","article-title":"Tanshinone IIA promotes the apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis by up-regulating lncRNA GAS5","volume":"38","author":"Li","year":"2018","journal-title":"Biosci Rep"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrc3195","article-title":"Are snoRNAs and snoRNA host genes new players in cancer?","volume":"12","author":"Williams","year":"2012","journal-title":"Nat Review"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1124\/mol.110.064055","article-title":"Inhibition of human T-cell proliferation by mammalian target of rapamycin (mTOR) antagonists requires noncoding RNA growth-arrest-specific transcript 5 (GAS5)","volume":"78","author":"Mourtada-Maarabouni","year":"2010","journal-title":"Mol Pharmacol"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-014-2974-y","article-title":"Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: Implications for chemotherapy","volume":"145","author":"Pickard","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/bs.apcsb.2016.10.002","article-title":"The functional stability of FOXP3 and RORgammat in Treg and Th17 and their therapeutic applications","volume":"107","author":"Ren","year":"2017","journal-title":"Adv Protein Chem Struct Biol"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1038\/sj.onc.1207755","article-title":"Oncogenic potential of the RUNX gene family: \u2018Overview\u2019","volume":"23","author":"Ito","year":"2004","journal-title":"Oncogene"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrc3877","article-title":"The RUNX family: Developmental regulators in cancer","volume":"15","author":"Ito","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(00)80986-1","article-title":"AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis","volume":"84","author":"Okuda","year":"1996","journal-title":"Cell"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1040-8428(02)00003-3","article-title":"The role of a Runt domain transcription factor AML1\/RUNX1 in leukemogenesis and its clinical implications","volume":"45","author":"Asou","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2567.2010.03381.x","article-title":"Interplay of transcription factors in T-cell differentiation and function: the role of Runx","volume":"132","author":"Wong","year":"2011","journal-title":"Immunology"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ni.1663","article-title":"Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17- producing T cells","volume":"9","author":"Zhang","year":"2008","journal-title":"Nat Immunol"},{"key":"R27-20250804","first-page":"2386","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Am Soc Hematol"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2012-07-442392","article-title":"Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group","volume":"121","author":"Rodeghiero","year":"2013","journal-title":"Blood"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3324\/haematol.2009.007823","article-title":"Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura","volume":"94","author":"Zhang","year":"2009","journal-title":"Haematologica"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"106127","DOI":"10.1016\/j.intimp.2019.106127","article-title":"LncRNA GAS5 inhibits Th17 differentiation and alleviates immune thrombocytopenia via promoting the ubiquitination of STAT3","volume":"80","author":"Li","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.humimm.2016.06.004","article-title":"Increased RUNX1 expression in patients with immune thrombocytopenia","volume":"77","author":"Zhong","year":"2016","journal-title":"Hum Immunol"},{"key":"R32-20250804","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1097\/MPH.0000000000002108","article-title":"Increased expression of IL-17A and IL-17F is correlated with RUNX1 and ROR\u03b3T in pediatric patients with primary immune thrombocytopenia","volume":"43","author":"Elnaenaey","year":"2021","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:07:54Z","timestamp":1754338074000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002580","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,19]]},"assertion":[{"value":"2022-03-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}